Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers

NCT02265653 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIIL 284 BS tablet C
DRUG: BIIL 284 BS tablet D
DRUG: BIIL 284 BS WIF tablet

Sponsor

Boehringer Ingelheim